T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment
about
Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challengesConformational states and recognition of amyloidogenic peptides of human insulin-degrading enzymeA current perspective on applications of macrocyclic-peptide-based high-affinity ligandsTargeted rescue of cancer-associated IDH1 mutant activity using an engineered synthetic antibody.Bacteriophage-fused peptides for serodiagnosis of human strongyloidiasis.Probing the functions of the paramyxovirus glycoproteins F and HN with a panel of synthetic antibodies.Generating conformation-specific synthetic antibodies to trap proteins in selected functional statesA synthetic antibody fragment targeting nicastrin affects assembly and trafficking of γ-secretase.Applications for an engineered Protein-G variant with a pH controllable affinity to antibody fragments.Assessment of a method to characterize antibody selectivity and specificity for use in immunoprecipitation.A New Versatile Immobilization Tag Based on the Ultra High Affinity and Reversibility of the Calmodulin-Calmodulin Binding Peptide Interaction.Generation of MANAbodies specific to HLA-restricted epitopes encoded by somatically mutated genes.Optimizing Production of Antigens and Fabs in the Context of Generating Recombinant Antibodies to Human ProteinsEngineering Synthetic Antibody Inhibitors Specific for LD2 or LD4 Motifs of Paxillin.A YidC-like Protein in the Archaeal Plasma Membrane.A polar ring endows improved specificity to an antibody fragment.A High Through-put Platform for Recombinant Antibodies to Folded Proteins.Generating Conformation and Complex-Specific Synthetic Antibodies.Architecture of the fungal nuclear pore inner ring complex.Conformational Chaperones for Structural Studies of Membrane Proteins Using Antibody Phage Display with NanodiscsTrastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells.Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy.A synthetic intrabody-based selective and generic inhibitor of GPCR endocytosis.Engineered synthetic antibodies as probes to quantify the energetic contributions of ligand binding to conformational changes in proteins.Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme.
P2860
Q26995399-7828C6B2-78CB-4B3A-ABC6-43E5C7D6C000Q27679412-FF4CCB62-5124-4BD8-B0F7-B3A2663F4F06Q28072407-C4F6FF5C-4148-40E0-B7F2-01644BD60096Q33678027-0CBDEF4A-06EA-46D2-99F6-14AB78455A40Q33685519-9E863555-2E0A-4881-864C-692432AA9B2FQ34261586-6C143730-9BD3-486E-AF61-1FC16A73E807Q34528889-FA1CB2FC-7DE7-4691-95FD-5A99897822D4Q34683369-E24F3D23-FE34-4E42-9ACA-659EFAD93592Q35467497-5411E75A-98B8-48C8-9BF6-F467ED9122E6Q35677278-8C1F9772-8CBC-4E9C-B97C-6BFD06308BFBQ35687367-697A5D18-B745-41DA-869B-83B02CADB0D1Q35718060-DFBB6652-EE42-400C-A8CA-3CBB86DB6D61Q35799354-3482D8CF-9083-4CAD-94C2-9CD5B8432398Q35907062-23BB42BB-8296-4A97-BA8D-3E190A5BAE4FQ36021187-7FA4D55A-0BF1-43F3-B2A4-BDFF7A00ED22Q36059271-8D3399EF-DF35-4C4F-B320-3E8E062F18EBQ36134059-5127B72F-58C0-4006-9D8E-878CADE80C41Q36296236-2E5DEABE-69D7-4C53-8567-53F31AB2F529Q36784744-CCE0DACB-8E90-4D43-9D13-FEA2C043984AQ38255135-472685EF-D656-40FA-BC2B-0B3DFB39D032Q38619194-B6C1B513-4251-4194-8DAC-1FBD323E2679Q47121798-09F54D7E-AF3A-4EBA-91CA-7029B8468CBFQ47716701-B573671A-9EB8-4956-AA57-312228FCF61EQ50102169-F14680F5-3F8F-4E35-8263-72DC87544B4EQ52622522-18128690-B077-4FBE-810E-0BA8A34A6F6D
P2860
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment
@ast
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment
@en
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment
@nl
type
label
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment
@ast
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment
@en
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment
@nl
prefLabel
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment
@ast
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment
@en
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment
@nl
P2093
P2860
P3181
P1433
P1476
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment
@en
P2093
Akiko Koide
Brenda Leung
Bryan Yoder
Edward J Collins
Jonathan Fitzsimmons
Keith R Miller
Michael Jay
Sachdev S Sidhu
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0043746
P407
P50
P577
2012-01-01T00:00:00Z